AXIM BIOTECHNOLOGIES, INC. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c2da5403-3b9a-495c-b738-712c2aa793a2/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-8.1M | 2023-01-01 – 2023-12-31 | evidence 0001096906-24-000864 |
| FY 2022 | $-2.8M | 2022-04-01 – 2023-03-31 | evidence 0001096906-24-001202 |
| FY 2021 | $-16.0M | 2021-01-01 – 2021-12-31 | evidence 0001096906-22-000902 |
| FY 2020 | $-6.4M | 2020-01-01 – 2020-12-31 | evidence 0001078782-21-000395 |
| FY 2019 | $-6.4M | 2019-01-01 – 2019-12-31 | evidence 0001078782-20-000359 |
| FY 2018 | $-6.8M | 2018-01-01 – 2018-12-31 | evidence 0001078782-19-000304 |
| FY 2017 | $-4.2M | 2017-01-01 – 2017-12-31 | evidence 0001078782-18-000306 |
| FY 2016 | $-5.8M | 2016-01-01 – 2016-12-31 | evidence 0001078782-17-000517 |
| FY 2015 | $-10.1M | 2015-01-01 – 2015-12-31 | evidence 0001078782-17-000517 |
| FY 2014 | $-582.9k | 2014-01-01 – 2014-12-31 | evidence 0001387308-15-000034 |
| FY 2013 | $-116.6k | 2010-11-19 – 2014-03-31 | evidence 0001078782-14-001122 |
| FY 2012 | $-25.6k | 2010-11-18 – 2013-03-31 | evidence 0001514955-13-000017 |
| FY 2011 | $-2.8k | 2011-01-01 – 2011-12-31 | evidence 0001514955-12-000006 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AXIM BIOTECHNOLOGIES, INC. — all facts · Revenue · Operating Income